PROEHL GERALD T

Insider Reports History

Reporting-owner location: San Diego, CA
Latest reporting-owner signature: /s/ S. Halle Vakani, as Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for PROEHL GERALD T

Form 4 holding President, CEO and Chairman, Director, 10%+ Owner

Dermata Therapeutics, Inc.

Security class: Common Stock
Shares / value: 490,255
Estimated value: $1,485,472
Report date: 23 Dec 2025
Price: $3.03
Ownership: By Proehl Family Trust

Form 4 holding President, CEO and Chairman, Director, 10%+ Owner

Dermata Therapeutics, Inc.

Security class: Common Stock
Shares / value: 122,563
Estimated value: $371,365
Report date: 23 Dec 2025
Price: $3.03
Ownership: By Sean Michael Proehl 2020 Irrevocable Trust Dated December 18, 2020

Form 4 holding Director

TENAX THERAPEUTICS, INC.

Security class: Pre-Funded Warrant
Shares / value: 31,654
Estimated value: $284,886
Report date: 09 Jan 2026
Price: $9.00
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 31,654

Form 4 holding Director

TENAX THERAPEUTICS, INC.

Security class: Stock Option (right to buy)
Shares / value: 30,000
Estimated value: $270,000
Report date: 09 Jan 2026
Price: $9.00
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 30,000

Form 4 holding President, CEO and Chairman, Director, 10%+ Owner

Dermata Therapeutics, Inc.

Security class: Common Stock
Shares / value: 79,795
Estimated value: $241,778
Report date: 23 Dec 2025
Price: $3.03
Ownership: By Proehl Investment Ventures LLC

Form 4 holding Director

TENAX THERAPEUTICS, INC.

Security class: Warrant
Shares / value: 16,660
Estimated value: $149,940
Report date: 09 Jan 2026
Price: $9.00
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 16,660

Form 4 holding Director

TENAX THERAPEUTICS, INC.

Security class: Common Stock
Shares / value: 1,667
Estimated value: $15,003
Report date: 09 Jan 2026
Price: $9.00
Ownership: Direct

Form 4 holding President, CEO and Chairman, Director, 10%+ Owner

Dermata Therapeutics, Inc.

Security class: Common Stock
Shares / value: 24
Estimated value: $72
Report date: 23 Dec 2025
Price: $3.03
Ownership: Direct

Form 4 holding President, CEO and Chairman, Director, 10%+ Owner

Dermata Therapeutics, Inc.

Security class: Common Stock
Shares / value: 7
Estimated value: $21
Report date: 23 Dec 2025
Price: $3.03
Ownership: By Allison Taylor Proehl 2020 Irrevocable Trust

Form 4 holding President, CEO and Chairman, Director, 10%+ Owner

Dermata Therapeutics, Inc.

Security class: Common Stock
Shares / value: 3
Estimated value: $9
Report date: 23 Dec 2025
Price: $3.03
Ownership: By Meghan Proehl Wilder 2020 Irrevocable Trust

Form 4 holding President, CEO and Chairman, Director, 10%+ Owner

Dermata Therapeutics, Inc.

Security class: Warrant (Right to Buy)
Shares / value: 787,402
Estimated value
Report date: 21 Jan 2025
Price
Ownership: By Proehl Investment Ventures LLC
Underlying class: Common Stock
Underlying amount

Form 4 holding President, CEO and Chairman, Director, 10%+ Owner

Dermata Therapeutics, Inc.

Security class: Series C Warrant (Right to Buy)
Shares / value: 490,496
Estimated value
Report date: 23 Dec 2025
Price
Ownership: By Proehl Family Trust
Underlying class: Common Stock
Underlying amount

Form 4 holding President, CEO and Chairman, Director, 10%+ Owner

Dermata Therapeutics, Inc.

Security class: Series D Warrant (Right to Buy)
Shares / value: 490,496
Estimated value
Report date: 23 Dec 2025
Price
Ownership: By Proehl Family Trust
Underlying class: Common Stock
Underlying amount

Form 4 holding President, CEO and Chairman, Director, 10%+ Owner

Dermata Therapeutics, Inc.

Security class: Series C Warrant (Right to Buy)
Shares / value: 122,549
Estimated value
Report date: 23 Dec 2025
Price
Ownership: By Sean Michael Proehl 2020 Irrevocable Trust Dated December 18, 2020
Underlying class: Common Stock
Underlying amount

Form 4 holding President, CEO and Chairman, Director, 10%+ Owner

Dermata Therapeutics, Inc.

Security class: Series D Warrant (Right to Buy)
Shares / value: 122,549
Estimated value
Report date: 23 Dec 2025
Price
Ownership: By Sean Michael Proehl 2020 Irrevocable Trust Dated December 18, 2020
Underlying class: Common Stock
Underlying amount

Form 4 holding President, CEO and Chairman, Director, 10%+ Owner

Dermata Therapeutics, Inc.

Security class: Warrant (Right to Buy)
Shares / value: 78,740
Estimated value
Report date: 23 Dec 2025
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding President, CEO and Chairman, Director, 10%+ Owner

Dermata Therapeutics, Inc.

Security class: Stock Option (right to buy)
Shares / value: 37,500
Estimated value
Report date: 02 Jan 2026
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by PROEHL GERALD T

4 TENX

TENAX THERAPEUTICS, INC.

Report period: 09 Jan 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 13 Jan 2026, 20:46
Role: Director
Next action: Open filing details

4 DRMA

Dermata Therapeutics, Inc.

Report period: 02 Jan 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 06 Jan 2026, 20:00
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 DRMA

Dermata Therapeutics, Inc.

Report period: 23 Dec 2025
Transactions: 8
Transaction value: $0
Accepted by SEC: 29 Dec 2025, 19:50
Role: PRESIDENT, CHAIRMAN, CEO, Director, 10%+ Owner
Next action: Open filing details

4 TENX

TENAX THERAPEUTICS, INC.

Report period: 01 Jul 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 03 Jul 2025, 08:11
Role: Director
Next action: Open filing details

4 DRMA

Dermata Therapeutics, Inc.

Report period: 21 Jan 2025
Transactions: 2
Transaction value: $0
Accepted by SEC: 23 Jan 2025, 17:02
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 DRMA

Dermata Therapeutics, Inc.

Report period: 13 Jan 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 14 Jan 2025, 18:50
Role: President, CEO and Chairman, Director
Next action: Open filing details

4 TENX

TENAX THERAPEUTICS, INC.

Report period: 10 Dec 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 12 Dec 2024, 20:07
Role: Director
Next action: Open filing details

4 TENX

TENAX THERAPEUTICS, INC.

Report period: 08 Aug 2024
Transactions: 3
Transaction value: $0
Accepted by SEC: 08 Aug 2024, 19:43
Role: Director
Next action: Open filing details

4 DRMA

Dermata Therapeutics, Inc.

Report period: 04 Jan 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 05 Jan 2024, 21:02
Role: President, CEO and Chairman, Director
Next action: Open filing details

4 TENX

TENAX THERAPEUTICS, INC.

Report period: 09 Jun 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 10 Jun 2022, 21:28
Role: Director
Next action: Open filing details

4 DRMA

Dermata Therapeutics, Inc.

Report period: 03 Jan 2022
Transactions: 4
Transaction value: $0
Accepted by SEC: 05 Jan 2022, 17:58
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 DRMA

Dermata Therapeutics, Inc.

Report period: 23 Nov 2021
Transactions: 1
Transaction value: +$48,000
Accepted by SEC: 26 Nov 2021, 12:30
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

4 DRMA

Dermata Therapeutics, Inc.

Report period: 16 Aug 2021
Transactions: 21
Transaction value: +$49,631
Accepted by SEC: 17 Aug 2021, 12:38
Role: President, CEO and Chairman, Director, 10%+ Owner
Next action: Open filing details

3 DRMA

Dermata Therapeutics, Inc.

Report period: 12 Aug 2021
Transactions: 0
Transaction value: $0
Accepted by SEC: 12 Aug 2021, 19:34
Role: Pres., CEO and Chairman, 10%+ Owner
Next action: Open filing details

4 TENX

TENAX THERAPEUTICS, INC.

Report period: 10 Jun 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 15 Jun 2021, 16:34
Role: Director
Next action: Open filing details

Insider Reports History

Continue from this owner filing history

Reported holdings for PROEHL GERALD T

Insider Reports Filed by PROEHL GERALD T